BlackRock Tactical Opportunities Instl (PBAIX)

Nasdaq Currently down 0.04 (-0.22%) in today's trading session

2 members of Congress have disclosed 5 trades in BlackRock Tactical Opportunities Instl (PBAIX) via STOCK Act filings. The most recent disclosure was a purchase by Larry D. Bucshon on 25 November 2024. The most active traders have been Chris Pappas (3) and Larry D. Bucshon (2). Aggregate disclosed activity totals roughly $16K in purchases and $24K in sales (midpoint estimates from bracketed disclosure amounts).

BlackRock Tactical Opportunities Instl is currently trading at $17.83, positioned at 98% of its 52-week range ($15.60 – $17.87).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$17.83
24h Change
-0.04 (-0.22%)
52 Week Range
$15.60$17.87
View on NASDAQ

BlackRock Tactical Opportunities Instl Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for PBAIX

Select to highlight on chart
5 transactions
Compliance: 0%
Larry D. Bucshon25 Nov 202428 Feb 2025PurchaseStock$1,001 - $15,000N/A
Chris Pappas10 Apr 20242 Aug 2025SaleStock$1,001 - $15,000N/A
Larry D. Bucshon25 Jan 202428 Feb 2025SaleStock$1,001 - $15,000N/A
Chris Pappas22 Mar 202313 Aug 2024SaleStock$1,001 - $15,000N/A
Chris Pappas16 Jul 202116 May 2022PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$5.88B

Volume

0

Beta

0.11

P/E Ratio

24.59

Fundamentals

EPS

$0.73

Div. Yield

-

Open

$17.87

Day Range

$17.83 – $17.87

Company Information

Sector
Financial Services
Industry
Asset Management
Exchange
NASDAQ · USD
Country
US
CEO
Emmanuel Roman
IPO Date
1993-06-01

The advisor uses a macro asset allocation strategy, investing varying percentages of its portfolio in global stocks, bonds, money market instruments, foreign currencies and cash. The advisor has wide flexibility in the relative weightings given to ea...

No earnings data available for this stock.

Dividends

Dividend History

20 Dec 2023
Amount $0.8740
20 Jul 2023
Amount $0.6950
19 Dec 2022
Amount $0.5080
23 Dec 2020
Amount $0.3790
23 Dec 2019
Amount $0.4560

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

EFG

iShares MSCI EAFE Growth ETF

47
$124.55+0.48 (+0.39%)
Financial Services
Held by same politician
Same sector: Financial Services
1 politician
View Stock

IVW

iShares S&P 500 Growth ETF

47
$140.55-0.19 (-0.14%)
Financial Services
Held by same politician
Same sector: Financial Services
1 politician
View Stock

VLUE

iShares MSCI USA Value Factor ETF

47
$205.51+1.64 (+0.80%)
Financial Services
Held by same politician
Same sector: Financial Services
1 politician
View Stock

Frequently Asked Questions about PBAIX

Which members of Congress have traded PBAIX?
2 members of Congress have disclosed 5 trades in BlackRock Tactical Opportunities Instl (PBAIX) under the STOCK Act. The most active traders are Chris Pappas and Larry D. Bucshon.
When was PBAIX most recently disclosed by Congress?
The most recent PBAIX disclosure was a purchase by Larry D. Bucshon on 25 November 2024.
What is the total disclosed congressional trading volume for PBAIX?
Members of Congress have disclosed approximately $16K in PBAIX purchases and $24K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in PBAIX?
This PBAIX page updates as soon as new STOCK Act disclosures are filed for BlackRock Tactical Opportunities Instl. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.